摘要
小活化RNA(saRNA)是小的双链RNA,其可以通过在转录和表观遗传水平上靶向基因启动子中的选定序列来介导靶特异性基因表达。这种基因操作现象被称为RNA激活(RNAa),与RNA干扰相比,它开辟了基于RNA的基因治疗的新途径。虽然由saRNA介导的RNAa的确切分子机制仍然仍然模糊,但一些研究提供了可能的解释它。此外,越来越多的证据表明,saRNA不仅提供了研究基因功能和操纵转录活性的新方法,而且还为临床治疗各种疾病,特别是癌症提供了巨大的潜力。癌症相关基因可被saRNA上调,以调节细胞周期和增殖,诱导细胞衰老和凋亡,抑制癌细胞侵袭和迁移,并逆转化疗耐药性。在此,我们总结了saRNA在上调特定基因表达方面的已知机制,并着重于saRNA在基因治疗中的潜在应用。此外,本综述还涉及对传递saRNA的机制和挑战的一些担忧。需要进一步说明saRNA的精确机制,并且期望开发用于saRNA的一些新型递送系统用于临床应用
关键词: 小活化RNA,RNA激活,基于RNA的基因治疗,基因治疗,癌症治疗,药物输送系统
Current Gene Therapy
Title:Current Advances in Small Activating RNAs for Gene Therapy: Principles, Applications and Challenges
Volume: 18 Issue: 3
关键词: 小活化RNA,RNA激活,基于RNA的基因治疗,基因治疗,癌症治疗,药物输送系统
摘要: Small activating RNAs (saRNAs) are small double-stranded RNAs that could mediate the target-specific gene expression by targeting selected sequences in gene promoters at both the transcriptional and epigenetic levels. This phenomenon of gene manipulation is known as RNA activation (RNAa), which opens up a new pathway for RNA-based gene therapeutics in contrast to RNA interference. Although the exact molecular mechanism of RNAa mediated by saRNAs still remains foggy, some studies have provided the possible ones to explain it. Furthermore, mounting evidence exhibit that saRNAs not only provide a new approach to study gene function and manipulate transcriptional activity, but also promise a great potential for clinical therapy against various diseases, especially cancer. Cancer-associated genes could be up-regulated by saRNAs to modulate cell cycle and proliferation, induce cell senescence and apoptosis, inhibit cancer cell invasion and migration, and reverse chemotherapy resistance. Herein, we summarize the known mechanisms of saRNAs on up-regulating specific gene expression and focus on the potential applications of saRNAs in gene therapy. In addition, some concerns about mechanisms and challenges for delivery of saRNAs are involved in this review. The precise mechanisms of saRNAs need to be further illustrated and some novel delivery systems for saRNAs are expected to be developed for clinical applications.
Export Options
About this article
Cite this article as:
Current Advances in Small Activating RNAs for Gene Therapy: Principles, Applications and Challenges, Current Gene Therapy 2018; 18 (3) . https://dx.doi.org/10.2174/1566523218666180619155018
DOI https://dx.doi.org/10.2174/1566523218666180619155018 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of a Human Hematopoietic Mesenchymal Progenitor in Wound Healing and Fibrotic Diseases and Implications for Therapy
Current Stem Cell Research & Therapy Synthesis and in vitro Anti-tumor Activity of Some New Sebacoyl Chloride Based Heterocycles
Current Organic Synthesis Patent Selections:
Recent Patents on Regenerative Medicine Ethanolic Extract of Berberis Vulgaris Fruits Inhibits the Proliferation of MCF-7 Breast Cancer Cell Line Through Induction of Apoptosis
Infectious Disorders - Drug Targets Deoxyribozymes as Inhibitors of Vascular Smooth Muscle Cell Growth
Current Pharmaceutical Biotechnology Recent Advances in Polymer Drug Conjugates
Mini-Reviews in Medicinal Chemistry Identification of Novel Anti-inflammatory Agents from Ayurvedic Medicine for Prevention of Chronic Diseases: “Reverse Pharmacology” and “Bedside to Bench” Approach
Current Drug Targets Histone Deacetylase Inhibitors in Cancer Therapy
Current Topics in Medicinal Chemistry An Integrated Chikungunya Virus Database to Facilitate Therapeutic Analysis: ChkVDb
Current Bioinformatics Preclinical and Clinical Studies on Bryostatins, A Class of Marine-Derived Protein Kinase C Modulators: A Mini-Review
Current Topics in Medicinal Chemistry Current and New Strategies for the Delivery of Antiseptic Agents
Current Drug Delivery Biomedical Potentialities of Taraxacum officinale-based Nanoparticles Biosynthesized Using Methanolic Leaf Extract
Current Pharmaceutical Biotechnology New Concepts for Glaucoma Implants - Controlled Aqueous Humor Drainage, Encapsulation Prevention and Local Drug Delivery
Current Pharmaceutical Biotechnology Anticancer Antioxidant Regulatory Functions of Phytochemicals
Current Medicinal Chemistry Suppression of NF-κB Signaling and P-glycoprotein Function by Gambogic Acid Synergistically Potentiates Adriamycin -induced Apoptosis in Lung Cancer
Current Cancer Drug Targets Ketoprofen Allergic Reactions
Recent Patents on Inflammation & Allergy Drug Discovery Nasal Drug Delivery System-Factors Affecting and Applications
Current Drug Therapy The p35 Family of Apoptosis Inhibitors
Current Genomics Melanoma
Current Cancer Therapy Reviews IL-17A and Multiple Sclerosis: Signaling Pathways, Producing Cells and Target Cells in the Central Nervous System
Current Drug Targets